Frontiers in T Cell Therapy
CAR-T cell therapies have quickly evolved from promising idea into powerful cancer treatment, one that turns the body’s own defenses against disease. As researchers seek to extend and improve on their early successes, what can we expect next?
This report was produced for Eureka Therapeutics by Scientific American Custom Media, a division separate from the magazine’s board of editors.
-
Medical & BiotechThe Unlikely Story of Cancer's Most Promising New Therapy
CAR-T cell therapy uses a patient’s own cells to fight blood cancers. How a simple idea was terribly complex to realize.
-
Medical & BiotechCAR-T 2.0: Safer, Armored, More Controlled
Three innovative spins on CAR-T cell therapy promise more benefits and reduced damage from cellular cancer treatments.
-
Medical & BiotechThe CAR-T Conundrum
For all their potential, CAR-T cell cancer therapies face significant obstacles. Bijan Nejadnik of Eureka Therapeutics explains one powerful method to overcome them.
-
Medical & BiotechRetooling T Cell Therapies to Target Solid Tumors
Cheng Liu, CEO and Chairman of Eureka Therapeutics, discusses how to beat both cancer and viral infections with treatments inspired by nature.
-
Medical & BiotechThe Tell-tale Targets Hidden Inside Solid Tumors
The next iterations of T cell therapy will go after intracellular targets that until now have been unavailable.
